MEDINET Co., Ltd. (2370.T)
JPY 31.0
(-3.13%)
JPY 31.0
(-3.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.35 Billion JPY | -7.88% |
| 2022 | -1.16 Billion JPY | -25.82% |
| 2021 | -718.52 Million JPY | -23.92% |
| 2020 | -672.89 Million JPY | 1.98% |
| 2019 | -572.44 Million JPY | 68.15% |
| 2018 | -2.83 Billion JPY | -80.68% |
| 2017 | -2.29 Billion JPY | 4.19% |
| 2016 | -1.26 Billion JPY | -8.93% |
| 2015 | -1.36 Billion JPY | -19.29% |
| 2014 | -1.36 Billion JPY | -81.51% |
| 2013 | -123.58 Million JPY | -31.07% |
| 2012 | -396.45 Million JPY | -163.73% |
| 2011 | -218.15 Million JPY | -134.76% |
| 2010 | 440.61 Million JPY | 15.77% |
| 2009 | 378.87 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -307.26 Million JPY | 7.82% |
| 2024 Q2 | -334.37 Million JPY | -17.77% |
| 2024 Q1 | -264.98 Million JPY | 27.53% |
| 2023 Q4 | -377.14 Million JPY | -1.43% |
| 2023 FY | - JPY | -7.88% |
| 2023 Q2 | -344.97 Million JPY | -7.35% |
| 2023 Q3 | -371.83 Million JPY | -7.79% |
| 2023 Q1 | -321.36 Million JPY | 5.74% |
| 2022 FY | - JPY | -25.82% |
| 2022 Q4 | -340.93 Million JPY | -10.5% |
| 2022 Q2 | -336.14 Million JPY | 0.11% |
| 2022 Q1 | -336.51 Million JPY | -15.66% |
| 2022 Q3 | -308.53 Million JPY | 8.21% |
| 2021 Q3 | -245.01 Million JPY | -1.92% |
| 2021 Q1 | -305.23 Million JPY | -5.87% |
| 2021 Q2 | -240.39 Million JPY | 21.24% |
| 2021 Q4 | -290.94 Million JPY | -18.75% |
| 2021 FY | - JPY | -23.92% |
| 2020 FY | - JPY | 1.98% |
| 2020 Q4 | -288.31 Million JPY | -4.73% |
| 2020 Q1 | -171.87 Million JPY | -42.37% |
| 2020 Q2 | -199.62 Million JPY | -16.15% |
| 2020 Q3 | -275.28 Million JPY | -37.9% |
| 2019 Q1 | -309.79 Million JPY | 9.78% |
| 2019 Q3 | -309.23 Million JPY | -17.53% |
| 2019 Q4 | -120.72 Million JPY | 60.96% |
| 2019 FY | - JPY | 68.15% |
| 2019 Q2 | -263.1 Million JPY | 15.07% |
| 2018 Q2 | -426.46 Million JPY | 71.84% |
| 2018 Q3 | -407.75 Million JPY | 4.39% |
| 2018 FY | - JPY | -80.68% |
| 2018 Q1 | -1.51 Billion JPY | -340.44% |
| 2018 Q4 | -343.38 Million JPY | 15.79% |
| 2017 Q1 | -300.17 Million JPY | 45.54% |
| 2017 FY | - JPY | 4.19% |
| 2017 Q2 | -638.23 Million JPY | -112.62% |
| 2017 Q4 | -343.84 Million JPY | 18.3% |
| 2017 Q3 | -420.84 Million JPY | 34.06% |
| 2016 Q4 | -551.21 Million JPY | -17.29% |
| 2016 Q1 | -357.86 Million JPY | 40.32% |
| 2016 Q2 | -421.11 Million JPY | -17.68% |
| 2016 Q3 | -469.95 Million JPY | -11.6% |
| 2016 FY | - JPY | -8.93% |
| 2015 FY | - JPY | -19.29% |
| 2015 Q2 | -296.19 Million JPY | -1.46% |
| 2015 Q4 | -599.68 Million JPY | -44.31% |
| 2015 Q3 | -415.54 Million JPY | -40.29% |
| 2015 Q1 | -291.93 Million JPY | 0.92% |
| 2014 Q2 | -338.47 Million JPY | -24.78% |
| 2014 FY | - JPY | -81.51% |
| 2014 Q4 | -294.65 Million JPY | 26.64% |
| 2014 Q3 | -401.64 Million JPY | -18.66% |
| 2014 Q1 | -271.26 Million JPY | -24.16% |
| 2013 Q2 | -223.03 Million JPY | -62.46% |
| 2013 Q3 | -244.4 Million JPY | -9.58% |
| 2013 Q4 | -218.47 Million JPY | 10.61% |
| 2013 FY | - JPY | -31.07% |
| 2013 Q1 | -137.28 Million JPY | 19.11% |
| 2012 Q3 | -225.94 Million JPY | -85.47% |
| 2012 Q1 | -161.69 Million JPY | -58.19% |
| 2012 FY | - JPY | -163.73% |
| 2012 Q2 | -121.82 Million JPY | 24.66% |
| 2012 Q4 | -169.71 Million JPY | 24.89% |
| 2011 FY | - JPY | -134.76% |
| 2011 Q3 | -147.57 Million JPY | -8444.88% |
| 2011 Q2 | -1.72 Million JPY | -102.39% |
| 2011 Q4 | -102.21 Million JPY | 30.74% |
| 2011 Q1 | 72.37 Million JPY | -44.5% |
| 2010 Q3 | 35.01 Million JPY | -77.6% |
| 2010 Q1 | 187.62 Million JPY | -12.92% |
| 2010 FY | - JPY | 15.77% |
| 2010 Q4 | 130.4 Million JPY | 272.41% |
| 2010 Q2 | 156.34 Million JPY | -16.67% |
| 2009 Q4 | 215.46 Million JPY | 24.5% |
| 2009 Q2 | 73.32 Million JPY | 42.37% |
| 2009 FY | - JPY | 0.0% |
| 2009 Q1 | 51.5 Million JPY | 0.0% |
| 2009 Q3 | 173.06 Million JPY | 136.03% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 241.515% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | -177.764% |
| GNI Group Ltd. | 14.48 Billion JPY | 109.358% |
| Linical Co., Ltd. | 1.24 Billion JPY | 208.709% |
| Trans Genic Inc. | 240.95 Million JPY | 662.708% |
| Soiken Holdings Inc. | -583.2 Million JPY | -132.483% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | -124.818% |
| AnGes, Inc. | -8.86 Billion JPY | 84.697% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -5.474% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 81.675% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 1158.378% |
| NanoCarrier Co., Ltd. | -863 Million JPY | -57.11% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | -24.187% |
| CanBas Co., Ltd. | 53.65 Million JPY | 2627.177% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | -74.816% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -1112.74% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | -11.894% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 1.808% |
| PeptiDream Inc. | 7.37 Billion JPY | 118.382% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 29.737% |
| Ribomic Inc. | -1.01 Billion JPY | -33.908% |
| SanBio Company Limited | -4.52 Billion JPY | 70.036% |
| Healios K.K. | -3 Billion JPY | 54.91% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -16.304% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 2.671% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 3.291% |
| StemRIM | -2.03 Billion JPY | 33.275% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 203.782% |
| FunPep Company Limited | -952 Million JPY | -42.422% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -52.556% |
| Stella Pharma Corporation | -723.85 Million JPY | -87.311% |
| TMS Co., Ltd. | -937 Million JPY | -44.702% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -74.861% |
| Cuorips Inc. | -518 Million JPY | -161.748% |
| K Pharma,Inc. | 366.05 Million JPY | 470.394% |
| Takara Bio Inc. | 8.02 Billion JPY | 116.898% |
| ReproCELL Incorporated | 8.24 Million JPY | 16544.585% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 1641.832% |
| StemCell Institute Inc. | 534.35 Million JPY | 353.737% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 653.831% |
| CellSeed Inc. | -836.51 Million JPY | -62.084% |